Ilika plc Trading Update & Notice of Results (0937A)

TIDMIKA

RNS Number : 0937A

Ilika plc

22 May 2023

Ilika plc

("Ilika" or the "Company")

Trading Update & Notice of Results

Analyst and Investor presentations

Ilika (AIM: IKA), a pioneer in solid-state battery technology, provides an update on trading, Stereax(R) manufacturing, and Goliath product development, as well as issuing its notice of full year results for the year ended 30 April 2023.

Trading Update for FY23

Unaudited trading for the year ended 30 April 2023 has been in line with management expectations. The Company expects to announce revenues of approximately GBP0.8m (2022: GBP0.5m), and an EBITDA loss excluding share-based payments of approximately GBP7.0m (2022: EBITDA loss of GBP6.4m). Cash and cash equivalents at the period end were GBP15.8m (30 April 2022: GBP23.4m).

Stereax Manufacturing Update

Following initial process qualification at its Stereax manufacturing facility in the UK, Ilika has been improving process yield and qualifying initial product batches. This enabled Ilika to release its first customer shipment of Stereax M50 cells in April 2023. The M50 cells can be used individually, but they are also the building blocks for Ilika's M300 batteries, which are made from six M50 cells connected in parallel. Ilika shipped its first batch of M300 batteries to customers earlier this month.

Ilika has 23 commercial orders from 20 customers, with miniature medical devices making up the majority of the demand. The applications cover 11 active implantable medical devices, three smart dental devices, two smart lenses, one for aerospace and three others.

Further to Ilika's announcement in January 2023, Ilika and Cirtec Medical LLC ('Cirtec'), a strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, are currently finalising the terms of their intended partnership. Ilika and Cirtec have signed a memorandum of understanding ('MOU') which outlines the transfer of Stereax(R) mm-scale battery manufacturing to Cirtec's facility in Lowell, Massachusetts, U.S. Following the transfer, Ilika will focus on advanced technology development and IP licensing in support of Cirtec's manufacturing and commercialisation activities.

Goliath Progress Update

Product development of Goliath, Ilika's large format battery for electric vehicles and consumer appliances, has continued to progress to schedule. Building on the significant improvement achieved in energy density (providing the potential for lighter weight battery packs) in the first half of the year, Ilika has focussed on increasing cycle life.

In parallel, Ilika has continued carrying out scale-up studies with partners to ensure its process is as compatible as possible with existing Gigafactory assets. In particular, Ilika has completed an equipment design study with Comau, an economic feasibility study with the UK Battery Industrialisation Centre (UKBIC) and is currently executing a series of trials on production-ready equipment.

Ilika continues to explore opportunities for closer collaboration with strategic partners interested in aligning their product roadmaps with Goliath. In February 2023, Ilika commenced leading a 24-month GBP8.2 million Faraday Battery Challenge collaboration programme to integrate high silicon content electrodes into its Goliath solid-state batteries to enable automotive level performance. The programme is supported by BMW and Williams Advanced Engineering.

Notice of Results

Ilika expects to announce its audited full year results for the year ended 30 April 2023 on Thursday 13 July 2023.

Analyst Briefing

The management team will be hosting an in-person analyst briefing on the day, Thursday 13 July 2023, at 9.30am. Analysts who wish to attend should contact Lianne Applegarth at Walbrook PR on +44(0)20 7933 8780 or email ilika@walbrookpr.com to register.

Investor Presentation

An investor presentation will be held on the day, Thursday 13 July 2023, at 4.30pm and will be hosted through the digital platform, Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Ilika plc via the following link: https://www.investormeetcompany.com/ilika-plc/register-investor or for more information please contact Walbrook PR at ilika@walbrookpr.com .

For more information contact:

 
 For more information contact: 
 Ilika plc                                                  www.ilika.com 
 Graeme Purdy, Chief Executive                            Via Walbrook PR 
 
 
 
 Liberum Capital Limited (Nomad                        Tel: 020 3100 2000 
  and Joint Broker) 
 Andrew Godber, 
 William Hall, Nikhil Varghese 
 
 
 Joh. Berenberg, Gossler & Co. KG                      Tel: 020 3207 8700 
  (Joint Broker) 
 Matthew Armitt, Mark Whitmore, Detlir 
  Elezi, 
 Mara Grasso 
 
 
 Walbrook PR Ltd                Tel: 020 7933 8780 / Ilika@walbrookpr.com 
 Lianne Applegarth                                     Mob: 07584 391 303 
 Nick Rome                                             Mob: 07748 325 236 
 Tom Cooper                                            Mob: 07971 221 972

About Ilika plc

Ilika specialises in the development of solid-state batteries. Its Stereax (R) product line is designed for miniature medical devices and specialist internet of Things (IoT) applications. Stereax (R) enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. For more information about Ilika, please visit: https://www.ilika.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFLFLREEIALIV

(END) Dow Jones Newswires

May 22, 2023 02:00 ET (06:00 GMT)

Ilika (AQSE:IKA.GB)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024